Supporting Effective Radiation Therapy for Early Stage Breast Cancer After Surgery
NCT01185132 · RecruitingThis trial looks at different ways to give radiation therapy for early stage breast cancer after a lumpectomy. It compares intensity modulated radiotherapy (IMRT) with standard 3D-conformal external beam radiotherapy. The goal is to see which method is more effective while also being safe and sparing healthy tissue.
Locations and contact
This trial is running at 5 locations in the United States. All of them are currently recruiting.
United States5 locations · 5 recruiting
- Rocky Mountain Cancer Centers - AuroraAurora, ColoradoRecruiting
- Rocky Mountain Cancer Centers - BoulderBoulder, ColoradoRecruiting
- Rocky Mountain Cancer Centers - LakewoodLakewood, ColoradoRecruiting
- Rocky Mountain Cancer Centers - LittletonLittleton, ColoradoRecruiting
- Rocky Mountain Cancer Centers - ThorntonThornton, ColoradoRecruiting
Who can join
Women and men aged 40 and older can join if they have early stage breast cancer. They should have certain types of tumors and meet other health criteria. Those who are pregnant or have specific health conditions cannot participate. The trial team will confirm who is eligible to join.
What happens during the trial
Participants are randomly placed into two groups. One group receives intensity modulated radiotherapy (IMRT), while the other group gets standard 3D-conformal radiotherapy. Both groups will receive the same total dose of radiation over 5 days. Everyone will be monitored for any side effects.
The trial team
The trial is sponsored by Rocky Mountain Cancer Centers, with Dr. Charles Leonard as the principal investigator.
Important dates
The trial started in July 2009 and is expected to finish by July 2028. It is currently enrolling new participants.
Additional information
This is a Phase 3 trial, which means it is looking at how well the treatments work and how safe they are. The trial hopes to include about 660 participants. The trial is regulated by the FDA.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →